Eva Temkin to Moderate at the Food and Drug Law Institute

Washington, D.C. FDA and Life Sciences partner Eva Temkin will moderate at the Food and Drug Law Institute on “Regulating Cell and Gene Therapies” on May 18 in Washington, D.C. Cell and gene therapy research and development continues to grow at a fast rate. FDA has issued recent guidance documents and undertaken an initiative to better enable informal meetings with industry, signaling interest in providing greater regulatory support and guidance to industry. Speakers will address these topics and delve further into how both FDA and industry can work to facilitate communication – and subsequent product development – in this ever-evolving area.